In 2000, Lawrence Arthur Cone, M.D., established the Genetic Research Institute of the Desert, merging his keen interest in infectious diseases and medical oncology with the field of genetics. Dr. Cone was Board Certified in Internal Medicine with subspecialties in Oncology, Immunology and Infectious Diseases. Dr. Cone published hundreds of clinical abstracts, research papers and medical texts. He was a sought after speaker, presenting his research abroad. His dream of starting a hands on Genetics research laboratory in the Coachella Valley was turned into reality after an enthusiastic, young medical genetics researcher from City of Hope Medical Center, Duarte, California approached him with the same interest. Lawrence Cone's research in the etiology of disease was extensive and far-reaching including diseases from asthma, hepatitis and endocarditis, pneumonia and sepsis to mycobacterium avium, acquired immune deficiency syndrome (AIDS), multiple sclerosis breast cancer, prostate cancer, melanoma and lung cancer. In 2003, after reviewing GRID major work breakthrough in breast cancer Mr. John Curci agreed to provide lab space in their new Cancer Center building at Eisenhower medical Center campus built in memory of his wife Mrs. Lucy Curci. An esteemed researcher and clinical diagnostician Dr. Cone at age 81, passed away July 10, 2009 in Rancho Mirage, California. In his honor, Board of Directors at GRID and Eisenhower medical center decided to continue and extend their services to GRID. New physician researchers joined the Board to join the mission and follow Dr. Cone’s vision - GRID. Genetic Research Institute of the Desert, is now recognized as the only molecular genetics research lab conducting research and training in the Imperial Inland Empire covering all the major seven cities surrounding Rancho Mirage. Our projects main focus is understanding the potential role of gene/s in an individual in developing cancer and/or other diseases. The ultimate goal is to develop preventative and therapeutic strategies to an individual's unique genome through innovative medical research, a hall mark of Personalized medicine.